Clinical Trial Update: Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating peg-aspargase with combination chemotherapy in younger patients with newly diagnosed high-risk acute lymphoblastic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Childhood Acute Lymphoblastic Leukemia

Drugs mentioned

• Pegaspargase (pegaspargase)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2016-12-07